Enzo Biochem Investor Relations Material
Latest events
Q1 2023
Enzo Biochem
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Enzo Biochem Inc
Access all reports
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. Our products include DNA probes and primers; cell imaging systems; hematology-based products that automate the identification of abnormal cells in blood; and research kits. The company also provides clinical lab services to physicians, medical centers, and other clinicians. The company serves clients worldwide.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States